The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study*
Abstract
OBJECTIVE: The optimal adrenergic support in shock is controversial. We investigated whether dopamine administration influences the outcome from shock. DESIGN: Cohort, multiple-center, observational study. SETTING: One hundred and ninety-eight European intensive care units. PATIENTS: All adult patients admitted to a participating intensive care unit between May 1 and May 15, 2002. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Patients were followed up until death, until hospital discharge, or for 60 days. Shock was defined as hemodynamic compromise necessitating the administration of vasopressor catecholamines. Of 3,147 patients, 1,058 (33.6%) had shock at any time; 462 (14.7%) had septic shock. The intensive care unit mortality rate for shock was 38.3% and 47.4% for septic shock. Of patients in shock, 375 (35.4%) received dopamine (dopamine group) and 683 (64.6%) never received dopamine. Age, gender, Simplified Acute Physiology Score II, and Sequential Organ Failure Assessment score were comparable between the two groups. The dopamine group had higher intensive care unit (42.9% vs. 35.7%, p=.02) and hospital (49.9% vs. 41.7%, p=.01) mortality rates. A Kaplan-Meier survival curve showed diminished 30 day-survival in the dopamine group (log rank=4.6, p=.032). In a multivariate analysis with intensive care unit outcome as the dependent factor, age, cancer, medical admissions, higher mean Sequential Organ Failure Assessment score, higher mean fluid balance, and dopamine administration were independent risk factors for intensive care unit mortality in patients with shock. CONCLUSIONS: This observational study suggests that dopamine administration may be associated with increased mortality rates in shock. There is a need for a prospective study comparing dopamine with other catecholamines in the management of circulatory shock.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Self-citationEarly goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Self-citationSurviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
Self-citationSurviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,018
Self-citationDellinger, R. P. (2004) · Critical Care Medicine · Cited by 1,848
Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial
(2000) · The Lancet · doi:10.1016/s0140-6736(00)03495-4 · Cited by 997
Pronovost, P. J. (1999) · JAMA · doi:10.1001/jama.281.14.1310 · Cited by 688
Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update
Hollenberg, S. M., Ahrens, T. S., Annane, D., Astiz, M. E., Chalfin, D. B., Dasta, J. F., Heard, S. O., Martin, C., Napolitano, L. M., Susla, G. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000139761.05492.d6 · Cited by 521
Self-citationNorepinephrine or Dopamine for the Treatment of Hyperdynamic Septic Shock?
Martin, C., Papazian, L., Perrin, G., Saux, P., & Gouin, F. (1993) · Chest · doi:10.1378/chest.103.6.1826 · Cited by 460
De Backer, D., Creteur, J., Silva, E., & Vincent, J.-L. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000063045.77339.b6 · Cited by 371
Self-citationEffect of norepinephrine on the outcome of septic shock
Martin, C., Viviand, X., Leone, M., & Thirion, X. (2000) · Critical Care Medicine · doi:10.1097/00003246-200008000-00012 · Cited by 366
Regional blood flow and oxygen transport in septic shock
BUOKONEN, E., TAKALA, J., KARI, A., SAXÉN, H., MERTSOLA, J., & HANSEN, E. J. J. (1993) · Critical Care Medicine · doi:10.1097/00003246-199309000-00011 · Cited by 360
Bernard, G. R., Ely, E. W., Wright, T. J., Fraiz, J., Stasek, J. E., Russell, J. A., Mayers, I., Rosenfeld, B. A., Morris, P. E., Yan, S. B., et al. (2001) · Critical Care Medicine · doi:10.1097/00003246-200111000-00003 · Cited by 271
Effects of Norepinephrine on the Renal Vasculature in Normal and Endotoxemic Dogs
BELLOMO, R., KELLUM, J. A., WISNIEWSKI, S. R., PINSKY, M. R., & Ondulik, B. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.4.9802055 · Cited by 180
Duranteau, J., Sitbon, P., Teboul, J. L., Vicaut, E., Anguel, N., Richard, C., & Samii, K. (1999) · Critical Care Medicine · doi:10.1097/00003246-199905000-00021 · Cited by 173
Dopamine suppresses pituitary function in infants and children
den Berghe, G. V., de Zegher, F., & Lauwers, P. (1994) · Critical Care Medicine · doi:10.1097/00003246-199422110-00008 · Cited by 151
Dopamine suppresses pituitary function in infants and children
den Berghe, G. V., de Zegher, F., & Lauwers, P. (1995) · Pediatric Nephrology · doi:10.1007/bf00866735 · Cited by 138
Devins, S. S., MILLER, A., Herndon, B., OʼTOOLE, L., & Reisz, G. R. (1992) · Critical Care Medicine · doi:10.1097/00003246-199212000-00007 · Cited by 128
Ruokonen, E., Takala, J. A., & Kari, A. (1993) · Critical Care Medicine · doi:10.1097/00003246-199309000-00012 · Cited by 91
Augmentation of Endogenous Dopamine Production Increases Lung Liquid Clearance
Adir, Y., Azzam, Z. S., Lecuona, E., Leal, S., Pesce, L. M., Dumasius, V., Bertorello, A. M., Factor, P. H., Young, J. K., Ridge, K. M., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-744oc · Cited by 30
Cited by
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
Self-citationCecconi, M., De Backer, D., Antonelli, M., Beale, R., Bakker, J., Hofer, C., Jaeschke, R., Mebazaa, A., Pinsky, M. R., Teboul, J. L., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3525-z · Cited by 1,767
Self-citationVincent, J.-L., & De Backer, D. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208943 · Cited by 1,425
Self-citationBrierley, J., Carcillo, J. A., Choong, K., Cornell, T., DeCaen, A., Deymann, A., Doctor, A., Davis, A., Duff, J., Dugas, M.-A., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819323c6 · Cited by 1,073
Davis, A. L., Carcillo, J. A., Aneja, R. K., Deymann, A. J., Lin, J. C., Nguyen, T. C., Okhuysen-Cawley, R. S., Relvas, M. S., Rozenfeld, R. A., Skippen, P. W., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002425 · Cited by 670
Metadata
- Authors
- Sakr, Y., Reinhart, K., Vincent, J.-L., Sprung, C. L., Moreno, R., Ranieri, V. M., De Backer, D., & Payen, D.
- Venue
- Critical Care Medicine
- Published
- 2006-03
- Volume
- 34
- Issue
- 3
- Pages
- 589-597
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2029949452
- Cited by
- 404
- References
- 24
- FWCI
- 21.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.